A study led by researchers at Hadassah University Hospital in Jerusalem was conducted on lab mice to test whether a non-psychoactive cannabinoid called cannabidiol would have an effect on type 1 diabetes. Researchers injected mice with 5mg of cannabidiol daily and reported that this procedure significantly reduced the prevalence of diabetes. The incidence of non-treated mice was around 86% while mice treated with cannabidiol proved to have an incidence of 30%. Researchers also reported lowered plasma levels of pro-inflamatories as well as lowered white blood cell swelling. It was concluded that the non-psychoactive cannabinoid had overwhelmingly positive effects on lab mice who were infected with type 1 diabetes.
For further reading on this study please visit: